1.19. Analysis.

Comparison 1 ICS versus placebo, parallel‐group studies, greater than 6 months (all doses), Outcome 19 Cataracts (no. of patients).

Comparison 1 ICS versus placebo, parallel‐group studies, greater than 6 months (all doses), Outcome 19 Cataracts (no. of patients).